Guangdong Huate Gas Co Ltd

Huate Gas said at its 2026 semi-annual results briefing on October 8 that the number of products for which it has achieved import substitution has increased from 22 at the time of its IPO to 57, and that it will focus on commercializing high-end electronic specialty gases such as disilane, hydrogen bromide, and boron trichloride. In response to investor questions about continued share reductions by employee shareholding platforms and senior executives, the company said that the three entities, including Xiamen Huahong Duofu, are all pre-IPO employee shareholding platforms established in 2012, and that the reductions were driven by partners' capital planning needs. There was no cashing out at highs or lack of confidence in the company's development, and block trades with certain discounts were chosen to improve reduction efficiency and reduce the impact on the secondary market. The company said its sales pricing comprehensively considers factors such as product costs, market competition, and customers' gas consumption scale, stability, and credit periods, with pricing characterized by case-by-case negotiation. On the performance front, the 2026 semi-annual report published on August 25 showed operating revenue of 872 million yuan, up 28.95 percent year on year; net profit attributable to the parent company of 92.83 million yuan, up 19.16 percent; non-GAAP net profit attributable to the parent company of 89.94 million yuan, up 19.29 percent; and net operating cash flow of 133 million yuan, up 46.93 percent year on year. In the first half, specialty gas business revenue reached 586.04 million yuan, up 38.56 percent year on year, semiconductor segment revenue reached 342.89 million yuan, up 28.22 percent year on year, and helium and related products accounted for about 20 percent of total operating revenue, with revenue up 133 percent year on year.

Huate Gas released its 2026 half-year report, showing first-half net profit attributable to the parent of 92.83 million yuan, up 19.2% year on year. Operating revenue was 872 million yuan, up 29.0% year on year. Net profit attributable to the parent after deducting non-recurring items was 89.94 million yuan, up 19.3% year on year. Net operating cash flow was 133 million yuan, up 46.9% year on year. Second-quarter operating revenue was 488 million yuan, up 44.2% year on year, and net profit attributable to the parent was 58.96 million yuan, up 75.9% year on year. The company said specialty gas business grew significantly, with higher sales volumes of photolithography and other mixed gases and fluorocarbon gases. Helium and related products accounted for about 20% of total revenue, up 133% year on year.

Huate Gas disclosed its 2026 interim report. In the first half, it achieved operating revenue of 872 million yuan, up 28.95% year on year. Net profit attributable to shareholders of the listed company was 92.83 million yuan, up 19.16% year on year. Basic earnings per share were 0.78 yuan. During the reporting period, the company leveraged its stable and reliable supply capabilities to drive higher sales volumes and increased sales profits for some core specialty gas products, including photolithography and other mixed gases, and fluorocarbon gases.

Huate Gas issued an earnings forecast, expecting net profit attributable to owners of the parent for the first half of 2026 to be 92.99 million yuan, up 19.36 percent year-on-year. The company said the profit growth was mainly due to its stable and reliable supply capabilities during the reporting period, which drove higher sales volumes for some core specialty gas products and increased gross profit from sales.

In early trading on July 13, industrial gas concept stocks opened sharply higher. Shuifa Gas hit its daily limit up at the open. Jinhong Gas and Huate Gas were among the top gainers, while Kemet Gas and Hangyang also surged to their daily limits. On the news front, the Ministry of Commerce and the General Administration of Customs announced on July 10 temporary export controls on helium. The traditional Chinese medicine sector was active, with Yiling Pharmaceutical, Kangyuan Pharmaceutical, and Taiji Group among the top gainers. Longshenrongfa rose over 16 percent, and Harbin Pharmaceutical and Lifang Pharmaceutical hit their daily limits. This followed the State Council's approval of the 15th Five-Year Plan for the Revitalization and Development of Traditional Chinese Medicine. In Hong Kong, the market opened lower but then moved higher, with the Hang Seng Tech Index briefly gaining over 1 percent.

China's Ministry of Commerce and the General Administration of Customs issued a notice on July 10, imposing temporary export ban management on helium, triggering a sharp opening surge for industrial gas concept stocks on the morning of July 13. Jinhong Gas and Huate Gas led the gains, Shuifa Gas hit the daily limit at the open, Jovo Energy locked in its second consecutive daily limit, and stocks such as KMT Gas and Hangzhou Oxygen also hit their daily limits. Helium is hailed as the 'golden gas' and is indispensable in semiconductor manufacturing. With demand surging recently, Zhang Zhijun, deputy manager of the production department at Shanghai Youjiali Specialty Gases, said daily output has doubled compared with the start of the year. The China Industrial Gases Industry Association noted in a statement that this move is an important measure to safeguard helium resource security and promote high-quality development of the industry, and will help maintain the stability of the global gas supply chain.